Модулирование действия ядерных рецепторов и регуляция биотрансформации лекарств
Аннотация
Об авторах
С. Н. ЛаринаРоссия
Н. В. Чебышев
Россия
Е. В. Ших
Россия
Список литературы
1. Shulman A. I., Mangelsdorf D. J. Retinoid X receptor heterodimers in the metabolic syndrome. N Engl J Med 2005; 353: 604-615.
2. Greschic H., Moras D. Structure - activity relationship of nuclear receptor - ligand interactions. Curr Top Med Chem 2003; 3: 1573-1599.
3. Hermanson O., Glass C. K., Rosenfeld M. G. Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 2002; 13: 55-60.
4. Jordan V. C. Antioestrogens and selective oestrogen receptor modulators as multifunctional medicines. Clinical considerations and new agents. J Med Chem 2003; 46: 1081-1111.
5. Gronemeyer H., Gustaffson J. A., Laudet V. Principles for modulation of the nuclear receptor superfamily. Nature Rev Drug Discovery 2004; 3: 950-964.
6. Liu M. M. et. al. Oppossing action of estrogen receptors a and ß on cyclin D1 gene expression. J Biol Chem 2000; 277: 24353-24360.
7. Shang Y., Hu X., Di Renzo J. et al. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000; 103: 843-852.
8. Shang Y., Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002; 295: 2465-2468.
9. Kliewer S. A., Goodwin B., Wilson T. M. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002; 23: 687-702.
10. Kliewer S. A., Moore J. T., Wade L. et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998; 92: 73-82.
11. Orans J., Teotico D. J., Redinbo M. R. The nuclear xenobiotic receptor Pregnane X Receptor: recent insights and new challenges. Mol Endocrinol 2005; 19: 2891-2900.
12. Sonoda J., Chong L. W., Downes M. et al. Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc Natl Acad Sci USA 2005; 102: 2198-2203.
13. Watkins R. E., Wisely G. B., Moore L. B. et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 2001; 292: 2329-2333.
14. Honkakoski P., Negishi M. Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J Biol Chem 1997; 272: 14943-14949.
15. Moore L. B., Parks D. J., Jones S. A. et al. Orphan nuclear receptors, constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol Chem 2000; 275: 15122-15127.
16. Xie W., Barwick J. L., Simon C. M. et al. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 2000; 14: 3014-3023.
17. Kodama S., Koike C., Negishi M., Yamomoto Y. Nuclear receptors Car and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol 2004; 24: 7931-7940.
18. Saradhi M., Kumar N., Reddy R. C., Tyagi R. K. Pregnane and xenobiotic receptor (PXR): a promiscuous xenosensor in human health and disease. JER 2006: 10: 1: 1-12.
19. Lehmann J. M., Mckee D. D., Watson M. A. et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998; 102: 1016-1023.
20. Moore L. B., Maglich J. M., McKee D. D. et al. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol Endocrinol 2002; 16: 977-986.
21. Drocourt L., Ourlin J. C., Pascussi J. M. et al. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 2002; 277: 25125-25132.
22. Mangelsdorf D. G. , Evans R. M. The RXR heterodimers and orphan receptors. Cell 1995; 83 : 841-850.
23. Wan Y. J., An D., Cai Y. et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 2000; 20: 4436-4444.
Рецензия
Для цитирования:
Ларина С.Н., Чебышев Н.В., Ших Е.В. Модулирование действия ядерных рецепторов и регуляция биотрансформации лекарств. Антибиотики и Химиотерапия. 2009;54(5-6):69-75.
For citation:
Larina S.N., Chebyshev N.V., Shikh E.V. Modulation of Nuclear Receptor Action and Regulation of Medicines Biotransformation. Antibiot Khimioter = Antibiotics and Chemotherapy. 2009;54(5-6):69-75. (In Russ.)